197 related articles for article (PubMed ID: 21094191)
101. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
[TBL] [Abstract][Full Text] [Related]
102. Selective delivery of 5-fluorouracil (5-FU) to i.p. tissues using 5-FU microspheres in rats.
Hagiwara A; Sakakura C; Tsujimoto H; Imanishi T; Ohgaki M; Yamasaki J; Sawai K; Takahashi T; Fujita T; Yamamoto A; Muranishi S; Ikada Y
Anticancer Drugs; 1997 Feb; 8(2):182-8. PubMed ID: 9073314
[TBL] [Abstract][Full Text] [Related]
103. Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy.
Banerjee S; Sen K; Pal TK; Guha SK
Int J Pharm; 2012 Oct; 436(1-2):786-97. PubMed ID: 22884831
[TBL] [Abstract][Full Text] [Related]
104. Preparation of ethosomes and deformable liposomes encapsulated with 5-fluorouracil and their investigation of permeability and retention in hypertrophic scar.
Wo Y; Zhang Z; Zhang Y; Wang D; Pu Z; Su W; Qian Y; Li Y; Cui D
J Nanosci Nanotechnol; 2011 Sep; 11(9):7840-7. PubMed ID: 22097495
[TBL] [Abstract][Full Text] [Related]
105. Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice.
Hagiwara A; Sakakura C; Shirasu M; Yamasaki J; Togawa T; Takahashi T; Muranishi S; Hyon S; Ikada Y
Anticancer Drugs; 1998 Mar; 9(3):287-9. PubMed ID: 9625440
[TBL] [Abstract][Full Text] [Related]
106. Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release.
Arouri A; Trojnar J; Schmidt S; Hansen AH; Mollenhauer J; Mouritsen OG
PLoS One; 2015; 10(5):e0125508. PubMed ID: 25945937
[TBL] [Abstract][Full Text] [Related]
107. Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines.
Udofot O; Affram K; Israel B; Agyare E
Integr Cancer Sci Ther; 2015; 2(5):245-252. PubMed ID: 26691592
[TBL] [Abstract][Full Text] [Related]
108. A nanoparticle formulation that selectively transfects metastatic tumors in mice.
Yang J; Hendricks W; Liu G; McCaffery JM; Kinzler KW; Huso DL; Vogelstein B; Zhou S
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14717-22. PubMed ID: 23959886
[TBL] [Abstract][Full Text] [Related]
109. Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.
Udofot O; Affram K; Smith T; Tshabe B; Krishnan S; Sachdeva M; Agyare E
J Nat Sci; 2016; 2(1):. PubMed ID: 27200415
[TBL] [Abstract][Full Text] [Related]
110. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro.
El Maghraby GM; Williams AC; Barry BW
J Pharm Pharmacol; 2001 Aug; 53(8):1069-77. PubMed ID: 11518016
[TBL] [Abstract][Full Text] [Related]
111. Bio-mediated synthesis of 5-FU based nanoparticles employing orange fruit juice: a novel drug delivery system to treat skin fibrosarcoma in model animals.
Mohammad O; Faisal SM; Ahmad N; Rauf MA; Umar MS; Mujeeb AA; Pachauri P; Ahmed A; Kashif M; Ajmal M; Zubair S
Sci Rep; 2019 Aug; 9(1):12288. PubMed ID: 31444363
[TBL] [Abstract][Full Text] [Related]
112. The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™.
Patankar N; Anantha M; Ramsay E; Waterhouse D; Bally M
Pharm Res; 2011 Apr; 28(4):848-57. PubMed ID: 21181548
[TBL] [Abstract][Full Text] [Related]
113. Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia.
Chen KTJ; Militao GGC; Anantha M; Witzigmann D; Leung AWY; Bally MB
J Control Release; 2021 May; 333():246-257. PubMed ID: 33798663
[TBL] [Abstract][Full Text] [Related]
114. Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues.
Chander N; Basha G; Yan Cheng MH; Witzigmann D; Cullis PR
Mol Ther Methods Clin Dev; 2023 Sep; 30():235-245. PubMed ID: 37564393
[TBL] [Abstract][Full Text] [Related]
115. Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems.
Leung AK; Tam YY; Chen S; Hafez IM; Cullis PR
J Phys Chem B; 2015 Jul; 119(28):8698-706. PubMed ID: 26087393
[TBL] [Abstract][Full Text] [Related]
116. A Physiochemical,
Shah N; Soma SR; Quaye MB; Mahmoud D; Ahmed S; Malkoochi A; Obaid G
ACS Appl Bio Mater; 2024 Jun; ():. PubMed ID: 38934648
[TBL] [Abstract][Full Text] [Related]
117. Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications.
Walsh C; Ou K; Belliveau NM; Leaver TJ; Wild AW; Huft J; Lin PJ; Chen S; Leung AK; Lee JB; Hansen CL; Taylor RJ; Ramsay EC; Cullis PR
Methods Mol Biol; 2014; 1141():109-20. PubMed ID: 24567134
[TBL] [Abstract][Full Text] [Related]
118. Nano-Based Therapy for Treatment of Skin Cancer.
Gilani SJ; Jahangir MA; Chandrakala ; Rizwanullah M; Taleuzzaman M; Shahab MS; Shakeel K; Aqil M; Imam SS
Recent Pat Antiinfect Drug Discov; 2018; 13(2):151-163. PubMed ID: 30205801
[TBL] [Abstract][Full Text] [Related]
119. Synthesis of titanium dioxide nanotubes with liposomal covers for carrying and extended release of 5-FU as anticancer drug in the treatment of HeLa cells.
Heidari Khoee M; Khoee S; Lotfi M
Anal Biochem; 2019 May; 572():16-24. PubMed ID: 30831100
[TBL] [Abstract][Full Text] [Related]
120. Novel 5-Fluorouracil Carbonate-Loaded Liposome: Preparation,
Wang X; Wang A; Feng W; Wang D; Guo X; Wang X; Miao Q; Liu M; Xia G
Mol Pharm; 2022 Jul; 19(7):2061-2076. PubMed ID: 35731595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
